Table 2.
Clinical and demographic data
| Parameter | Anuric (n=12) | Nonanuric (n=12) | Total (n=24) |
|---|---|---|---|
| Males | 6 (50%) | 6 (50%) | 12 (50%) |
| Age (years) | 75 (64–82) | 52 (37–68) | 68 (46–78) |
| Weight (kg) | 79.0 (70.3–88.0) | 77.5 (65.5–88.0) | 78.0 (68.8–88.0) |
| Intraperitoneal gentamicin dose (mg) | 47.5 (41.0–55.0) | 47.5 (40.0–52.0) | 47.5 (40.0–52.0) |
| Intraperitoneal gentamicin dose (mg/kg) | 0.60 (0.59–0.60) | 0.60 (0.57–0.62) | 0.60 (0.58–0.61) |
| Urine output (ml/24 h) | 0 (0–42) | 533 (177–827) | 173 (19–625) |
| Peritoneal membrane type | |||
| low average | 3 (25%) | 3 (25%) | 6 (25%) |
| high average | 5 (42%) | 6 (50%) | 11 (46%) |
| high | 4 (33%) | 3 (25%) | 7 (29%) |
| Duration of intraperitoneal gentamicin therapy (days) | 3.5 (2–11) | 14 (4.5–21) | 5 (3–21) |
All values are reported as n (%) or median (interquartile range).